Melanie Ivarsson
Corporate Officer/Principal en MODERNA, INC. .
Cargos activos de Melanie Ivarsson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 30/01/2020 | - |
Loqus23 Therapeutics Ltd.
 Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Director/Board Member | 25/01/2022 | - |
Historial de carrera de Melanie Ivarsson
Antiguos cargos conocidos de Melanie Ivarsson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - | - |
Formación de Melanie Ivarsson.
| University of Bristol | Doctorate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 3 |
Operativa
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MODERNA, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
Loqus23 Therapeutics Ltd.
Loqus23 Therapeutics Ltd. BiotechnologyHealth Technology Loqus23 Therapeutics Ltd.engages in research and development of biotechnology. The company was founded on March 29, 2019 and is headquartered in in Reading, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Melanie Ivarsson
- Experiencia
